Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Aurinia Pharmaceuticals Q3 2026 Results: Net Income $31.7M, Up 0.5% YoY

Aurinia Pharmaceuticals reported a significant increase in net income to $103.5 million for the nine months ended September 30, 2026, compared to $76.4 million in the prior year period, driven by a 19% growth in total revenue. The company maintained a strong liquidity position with $486.9 million in cash and short-term investments while continuing its share repurchase program.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue83.773.5
Profit before tax38.732.0
Net income31.731.6
EPS (diluted, $ a share)$0.23$0.23

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+0.5%
Revenue, year on year+13.9%
Operating margin42.3%
Source

10-Q filed with the SEC, NASDAQ: AUPH. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Aurinia Pharmaceuticals Inc.: key numbers

Share price
$15.48Close, Nov 16
Market cap
$2.07B
Shares outstanding
134MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Aurinia Pharmaceuticals Inc.

All →
8:04 AM ET 8-K
Financial Results

Aurinia Pharmaceuticals Financial Results

Aurinia Pharmaceuticals reported Q3 2026 financial results with total revenue of $83.7 million, a 14% increase year-over-year, driven by $79.4 million in net product sales of LUPKYNIS. The company reported net income of $31.7 million and increased its full-year 2026 total revenue guidance to a range of $325 million to $330 million.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.